Back to search
FDAFDA · Food and drugs·Recall number D-0787-2026

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Published August 19, 2026 · Recall initiated: July 24, 2026

Summary

FDA records drug Class I recall D-0787-2026, published August 19, 2026 and initiated July 24, 2026. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 19,032 bags; Lot: Lot # LD175708, Exp Date: 14-Feb-2027. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Letter

Get an email if CEFAZOLIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEFAZOLIN
Manufacturer
Baxter Healthcare Corporation
Distributor
US Nationwide.
Lot
Lot # LD175708, Exp Date: 14-Feb-2027.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41. recalled?

Yes. FDA published recall D-0787-2026 on August 19, 2026. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEFAZOLIN.